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and Drug Administration, Bethesda, Maryland; and {Physics Department, Moscow State University, Moscow, RussiaABSTRACT Analysis of complex time-dependent biological networks is an important challenge in the current postgenomic era.
We propose a middle-out approach for decomposition and analysis of complex time-dependent biological networks based on: 1),
creation of a detailed mechanism-driven mathematical model of the network; 2), network response decomposition into several
physiologically relevant subtasks; and 3), subsequent decomposition of the model, with the help of task-oriented necessity and
sensitivity analysis into several modules that each control a single speciﬁc subtask, which is followed by further simpliﬁcation
employing temporal hierarchy reduction. The technique is tested and illustrated by studying blood coagulation. Five subtasks
(threshold, triggering, control by blood ﬂow velocity, spatial propagation, and localization), together with responsible modules,
can be identiﬁed for the coagulation network. We show that the task of coagulation triggering is completely regulated by
a two-step pathway containing a single positive feedback of factor V activation by thrombin. These theoretical predictions are
experimentally conﬁrmed by studies of ﬁbrin generation in normal, factor V-, and factor VIII-deﬁcient plasmas. The function of
the factor V-dependent feedback is to minimize temporal and parametrical intervals of ﬁbrin clot instability. We speculate that
this pathway serves to lessen possibility of ﬁbrin clot disruption by ﬂow and subsequent thromboembolism.INTRODUCTIONComplex reaction networks of signal transduction, gene
regulation, metabolism, etc., are ubiquitous in cells. They
govern numerous vital processes, including cell reproduc-
tion, development, homeostasis, interaction with environ-
ment and apoptosis. In multicellular organisms, they can
be found in the extracellular milieu as well; examples are
blood coagulation and complement.
Recent advances in high-throughput technologies pro-
vided an unprecedented amount of information about bio-
logical networks. This in turn became a stimulus for rapid
progress in their modeling, now widely used in its research,
being both time- and cost-saving as well as providing excep-
tional capabilities for system analysis, chemical engineering,
and experimental planning. Two general problems in this
field are system reconstruction (inference of structure or
parameters of a poorly known network from experimental
data (1)) and analysis (understanding functioning of a well-
defined network). Although the former might intuitively
appear more complex, the latter poses no less significant
challenges. There are powerful techniques for analysis of
steady-state systems (e.g., biochemical systems theory and
metabolic control analysis (2)), but few of the existing tools
can efficiently deal with complex networks that are non-
linear, time-, and/or space-dependent.
One way to decrease complexity of a network model is by
reduction—i.e., by a simplification that yields a more analyz-Submitted July 31, 2009, and accepted for publication January 15, 2010.
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one. Two reduction approaches applicable for any system are
removal of nonessential components (3) and segregation of
variables with different characteristic timescales (4–6). For
evolutionally formed biological systems having meaningful
functions, there is an additional possibility: decomposition,
i.e., identification of functional or structural modules in the
network (7–9). The central problem of decomposition is
how to identify the modules in the most optimal manner.
We propose here a strategy for decomposition and anal-
ysis of biological networks based on the combination of
modularity concept with sensitivity analysis and temporal
hierarchy reduction techniques. It assumes that physiological
function of a complex network can be divided into specific
subtasks (formation of bistability, oscillations, self-sustained
propagation, etc.), each controlled by a specific module.
To identify the modules, subtasks are characterized by
specific parameters within the overall system response (e.g.,
concentration amplitude, oscillation frequency, propagation
velocity, etc.), and the system is perturbed in order to identify
components responsible for each subtask. Temporal hier-
archy reduction is used to ultimately simplify the model
and reveal hidden regulation mechanisms.
The approach is tested and illustrated by studying control
of blood coagulation, with emphasis on the recognition of
activating signal. Previous studies employing different strat-
egies were able to suggest several modules in this network.
Here, we show that the module responsible for triggering
coagulation response includes reactions of extrinsic tenase
assembly, factor X, prothrombin, and factor V activation.doi: 10.1016/j.bpj.2010.01.027
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on fibrin generation in normal, factor V-, and factor VIII-
deficient plasmas. Their results confirm a critical role for
factor V-dependent positive feedback in coagulation trig-
gering. We suggest that the task of this module is to mini-
mize temporal and parametrical intervals wherein the fibrin
clot is not stable, thus reducing the possibility of thromboem-
bolism. Combining results of this study with previous
reports suggests that coagulation has at least five specific
subtasks within the framework of its general goal, which is
to form a spatially localized fibrin clot at the site of vascular
damage.MATERIALS AND METHODS
Mathematical model
A model of coagulation developed earlier by our group (10) was used with
modifications. An in-depth description is available as Supporting Material.
Briefly, this detailed mechanism-driven model was constructed using the
bottom-up principle and extensively corroborated with experiments. The
model contains 24 ordinary differential equations. Its variables are concen-
trations of coagulation factors and inhibitors; parameters are rate constants
for reactions of coagulation factor activation and inhibition, binding to phos-
pholipids, etc. All parameters were from experimental reports without
adjustment except for choosing between values reported by different groups.
It was numerically integrated using the ode45 solver implemented in
MATLAB (Ver. R2008a; The MathWorks, Natick, MA).
Materials
Rabbit brain TF from Renam (Moscow, Russia) was calibrated using an
Actichrome TF chromogenic activity kit from American Diagnostica (Stam-
ford, CT). Human plasma-derived affinity-purified factor VIII (11) was
a generous gift of Prof. Eugene L. Saenko (University of Maryland School
of Medicine, Baltimore, MD). Specific factor XIIa inhibitor (corn trypsin
inhibitor, CTI) was prepared from corn seeds as described (12).
Plasma preparation
Normal and factor VIII-deficient plasmas were prepared from whole blood
collected from healthy volunteers and severe hemophilia A patients, respec-
tively, under Center for Theoretical Problems of Physicochemical Pharma-
cology Ethical Committee approval. Blood was drawn into 3.8% sodium
citrate (pH 5.5) at 9:1 blood/anticoagulant volume ratio, supplemented
with CTI at 0.4 mg/mL final concentration to inhibit contact activation,
and centrifuged at 1000 g for 25 min. The supernatant was additionally
centrifuged at 10,000 g for 5 min to obtain platelet-free plasma. Plasma
was lactate-treated to stabilize pH at 7.2–7.4 (13). Frozen human pooled
factor V congenitally deficient plasma was from George King Bio-Medical
(Overland Park, KS). It was supplemented with CTI and incubated at 37C
for 4 h after thawing to allow inhibition of enzymes generated due to cold-
induced activation (14); then it was processed as normal plasma.
Fibrin generation experiments
The assay was carried out in 96-well plates as described (14) with minor
modifications. Coagulation was started by addition of TF/CaCl2 (final
concentration 20 mM CaCl2, which corresponds to 2.5 mM free calcium).
The plate was read for 300 min in a Thermomax microplate reader (Molec-
ular Devices, Sunnyvale, CA), thermoregulated at 37C, at the wavelength
of 405 nm.Biophysical Journal 98(9) 1751–1761Task-oriented decomposition
Basic assumption
The global task of a complex biological network can be differentiated into
several subtasks, each controlled by a specific module (though modules
can overlap and control more than one subtask); each subtask can be char-
acterized by numerical parameters in the system output; system perturbation
can be used to identify modules corresponding to each output parameter and,
respectively, each subtask.
Step 1. Development of a detailed quantitative mathematical model of the
network. A detailed mechanism-driven model of the studied network is
a prerequisite.
Step 2. Identification of subtasks and outputs. A hypothesis about subtasks
of the network should be formulated as a starting point. Another critical
element is choice of output parameters for each subtask. Most sensitivity
analysis approaches use scaled sensitivity coefficients for concentrations
or fluxes in steady-state cases or more sophisticated indicators suitable for
time-dependent systems (15,16) to evaluate some overall response. Impor-
tantly, we suggest an opposing strategy: that dynamics of a complex biolog-
ical network is a combination of several simpler responses, and that the
selected outcomes should be specific.
Step 3. Task-oriented decomposition and reduction. 1), For each subtask,
the responsible module is identified using necessity and sensitivity analysis.
2), The model of each module is reduced using temporal hierarchy of
processes.
Step 4. Analysis of the reduced model and experimental test of the predic-
tions. Ideally, reduced models of the individual modules should contain few
differential equations and be susceptible to analysis. With such simplifica-
tion, the phenomena observed could be readily linked to specific reactions.
It would then be possible to propose a more detailed decomposition of the
networks if necessary, and to make predictions to be tested experimentally.
Blood coagulation
Coagulation is a network of enzymatic reactions in blood plasma and on
membranes of blood, vascular, and extravascular cells (17) that turn fluid
plasma into a gel upon injury, thus sealing the defect and preventing blood
loss. Maintaining a balance between fluid and solid states makes this
network vital: insufficient clotting can result in disabling or life-threatening
hemorrhages, whereas excessive clotting in the form of thrombosis, dissem-
inated intravascular coagulation, or other vascular disorders is even more
dangerous, making up for the lion’s share in human mortality and morbidity.
The cascade enzymes are serine proteases activating each other via prote-
olysis. Their lifetimes are limited due to protease inhibitors. Primary acti-
vator is a transmembrane protein tissue factor (TF) which is localized to
extravascular tissues and comes in contact with blood upon injury. The
complex of TF and factor VIIa activates factor X into Xa that activates
prothrombin into thrombin; thrombin converts fibrinogen into fibrin; fibrin
polymerizes to jellificate blood. In addition, thrombin activates factors
VIII, V, XI, and VII in positive feedback loops, and protein C in a negative
feedback; factor VII is also activated by factor Xa.
A striking observation is that only two reactions in the network have
obvious functions: binding of factor VIIa to TF recognizes the damaged
site, and fibrin polymerization converts plasma into gel. At a first glance, there
is no reasonwhy coagulation cannot consist just of the VIIa-TF complex acti-
vating fibrinogen: such a system would seemingly have all necessary parts,
i.e., the sensor and the effector. However, it is currently understood that the
task of coagulation is more complex. Several groups attempted to identify
its specific subtasks and link them to individual reactions:
1. to clot or not to clot: to recognize the site of damage and respond depend-
ing on TF concentration (18,19), size, and shape of the damaged region
(20,21);
2. to propagate in space, i.e., to form a solid three-dimensional clot closing
the wound instead of a thin fibrin film (10,22–24);
3. to localize growing thrombus (10); and
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secondary thrombi (25).RESULTS
Step 1: Mathematical model
A detailed mechanism-driven model of coagulation con-
structed using the bottom-up principle was used (see Mate-
rials and Methods).FIGURE 1 Kinetics of blood clotting in a homogeneous system. (A)
Fibrin generation in plasma activated with 5 pM TF, computer simulations.
using the model defined by Eqs. S1–S35 in the Supporting Material. Param-
eters in the panel: clot time (i.e., the time required to achieve 50% fibrinogen
cleavage); approximate fibrin jellification threshold; and total fibrin concen-
tration at the end of experiment. (B) Optical density increase in plasma upon
addition of 5 pM TF, three independent experiments each performed with
pools from three normal plasmas.Step 2: Identiﬁcation of subtasks and outputs
The focus of this study was on the control of activation recog-
nition in coagulation. Therefore, we considered a homoge-
neous system, without spatial heterogeneity and diffusion.
This is justified by the following considerations:
1. Homogeneous activation of clotting can occur in vivo
when caused by circulating TF (26); it is also a good
approximation of coagulation in a complete reaction-diffu-
sion-convection system if applied to a thin, well-mixed
layer of plasma adjacent to the activating TF-expressing
cells (27).
2. Most clotting assays in vitro such as thrombin generation
(28) are homogeneous, and our conclusions would be
valid for them as well.
3. Use of homogeneous approximation will allow us to build
useful and illustrative analytical solutions and phase
diagrams.
Coagulation was initiated in uniformly mixed samples of
plasma by addition of TF. Fibrin concentration (in the
model) or fibrin clot optical density (in the experiments)
was monitored (Fig. 1). For screening of network compo-
nents, clot time defined as time required to achieve 50%
conversion of fibrinogen into fibrin (14) was used. Note
that it is different from time of fibrin jellification, which
proceeds almost instantaneously in an explosive manner
after fibrin concentration exceeds some threshold level that
is <5% of plasma fibrinogen (29,30).
There are experimental indications that the coagulation
network has an activation threshold (31–33), i.e., the ability
to ignore small nonzero activation but respond fully once it
exceeds some value. However, its nature and responsible
mechanisms are unclear. One definition of threshold in clot-
ting is sharp transition of thrombin generation from linear to
explosive (31); another is existence of bifurcation (18) or bist-
ability (34) in thrombin formation response; the third one is
lack of clotting at low activation (21,32). Although such prop-
erties could be related, it is not necessarily so. As noted above,
there is a threshold fibrin concentration required for gel forma-
tion, and fibrin jellification can occur before, or without,
reaching explosive kinetics. This means that even if thrombin
amplitude were a linear function of activation, the whole
system might still have a clotting threshold. To distinguish
between possible definitions, we shall henceforth introducethe following distinction: nonlinear, explosive response will
be called ‘‘activation triggering’’, whereas the term ‘‘fibrin
jellification threshold’’ will be reserved for the ability to not
clot plasma at low activation.
Step 3: Task-oriented module identiﬁcation
and reduction
Essential components
Components essential for fibrin formation were identified
by task-oriented necessity and sensitivity analysis (see Sup-
porting Material). Briefly, protein concentrations and rate
constants were either set to zero to determine relative
changes of clot time Dtclot or perturbed to obtain control
coefficients Ctclot (Table S2). There were noncontrolling
necessary components such as fibrinogen and factor X (small
jCtclotj, infinite Dtclot), as well as controlling unnecessaryBiophysical Journal 98(9) 1751–1761
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tance could depend on conditions: for example, Ctclot for
AT-III was 0.25 at 5 pM of TF but infinite as TF concentra-
tion approached zero (Fig. S1). Factor V activation was the
only positive feedback that affected tclot. This was due not
to the network architecture, but to different reaction rates:
if other feedbacks were more rapid, their contribution could
have become significant (Fig. S2). Many components were
neither necessary nor controlling with regard to tclot and
could be eliminated, among them the negative feedback of
the protein C pathway.
Ultimately, this step allowed us to reduce the model down
to 15 differential equations (see SupportingMaterial) without
significant changes in system kinetics at low TF (Fig. 2).
Extrinsic tenase VIIa–TF, factor Xa, and thrombin concentra-
tions rapidly reached quasi-steady-state values (Fig. 2, insets)
and then changed slowly.
Tikhonov’s theorem
Tikhonov’s theorem (4,5) was used to carry out temporal
reduction (see Supporting Material). This identified three
crucial slow variables: the pool of TF-containing complexes
(x3p), thrombin (x2), and factor Va (x5). The reduced model
for the coagulation initiation module was8>>>>><
>>>>>:
dx3p
dt
¼ b2  x3p
dx2
dt
¼ b3  x3p  ða3 þ a4  x5Þ  a5  x2
dx5
dt
¼ a6  x2
x1 ¼ a7=a6  x5
; (1)
where aj and bj are constant parameters defined in Support-
ing Material. It is important to point out that absence of vari-Biophysical Journal 98(9) 1751–1761ables for the concentrations of factors VIIa, VII, Xa, X, V,
AT-III, etc., in this set does not mean that these factors are
absent from this model; they just do not have their individual
differential equations. The principle of temporal hierarchy
reduction employed during the stage B is that, during the
timescale of interest, these concentrations are either constant
(and are included in the parameters) or quasi-steady (and
can be calculated for any given timepoint on the basis of
other concentrations). This is fundamentally different from
the cases of protein C or factor VIII that do not affect clot
time at all and were removed during the stage A of the
reduction.
At low TF, concentrations could be obtained as explicit
functions of time:8>>>>><
>>>>>:
x73 ¼ x3jt¼ 0  b1  eb2  t
x10 ¼ x3jt¼ 0  b3  eb2  t
x2 ¼ x3jt¼ 0  b4  eb5  x3jt¼ 0 ð1e
b2  tÞ  eb2  t
x1 ¼ y1jt¼ 0 

1 e
b6
y1 jt¼ 0


e
b5  x3 jt¼ 0 ð1eb2  tÞ1
 :
(2)
Fig. 2 confirms that time courses of the variables are accu-
rately described by the expressions in Eq. 2, except for the
rapid processes of quasi-steady-state achievement.Step 4: System analysis and experimental
conﬁrmation
Steady states and dynamics
These are convenient to investigate in the phase space, where
coordinates are model variables, dynamics is represented as
trajectories, and steady states as attractors for them. BothFIGURE 2 Model reduction. Kinetics of coagulation in
plasma activated with TF at 0.01 pM: (A) the VIIa-TF
complex; (B) factor Xa; (C) thrombin; (D) fibrin. Model
reduction steps: 1), No reduction, computer simulations
with the original model; 2), Step A, nonessential compo-
nents are removed; and 3), Step B, temporal decomposi-
tion.
FIGURE 3 Dynamics of the system. (A and B) Projections of phase
space of the complete model (see Eqs. S1–S35 in the Supporting Material)
on the x3p-x2 plane in linear (A) or semilogarithmic (B) scale. Null-cline
projections dx2/dt ¼ 0 and dx3p/dt ¼ 0 are thick solid and shaded lines,
respectively. Arrows show directions of phase trajectories. Phase trajectories
are thin solid lines; thin dotted line in panel B shows trajectories at high TF
concentrations, when limitation on the amount of inactive precursors
becomes important. (C) Phase portrait for the reduced robusterized model
(see expressions in Eq. 3).
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reduced (expressions in Eq. 1) models have a single stable
steady state wherein concentrations of active enzymes are
zero (Supporting Material). Projection of the original model
phase space on the x3p-x2 plane is shown in Fig. 3, A and B.
Addition of activator x3p causes a pulse of thrombin concen-
tration x2 followed by return to the point of origin. Response
amplitude is a strongly nonlinear function of x3p (Fig. 3 B):
with initial x3p increase from 0.03 to 0.04 pM, maximal x2
is increased by more than three orders of magnitude. This
phase portrait can be deciphered and illustrated using a
modified version of the reduced model, wherein all positive
feedbacks are retained and factor Va inhibition is added for
‘‘robusterization’’ (see Supporting Material):8>>>><
>>>>:
dx3p
dt
¼ b2  x3p
dx2
dt
¼ x3p þ

a3 þ a4  x2

 x3p þ a5  x2
 ða1 þ a2  x2Þ  h  x2
:
(3)
Its portrait (Fig. 3 C) qualitatively retains principal features
of the complete system. There is a stable node at the point
of origin, and a strongly curved dx2/dt ¼ null-cline. A differ-
ence is a saddle at x2 s 0 that was hard to observe in the
complete system (Fig. 3, A and B) because of the limited
supply of pro-cofactors. But for this, thrombin generation
would become self-sustained and unstoppable if the
threshold is exceeded. Curiously, this threshold is in no
way related to fibrin formation: the saddle point and
threshold are formed by the positive feedback of XI activa-
tion by thrombin (compare Fig. 3 C with Fig. S3) that does
not affect clot time (Table S2).
Explosive clotting kinetics is determined by positive feed-
back of factor V activation. Kinetics of fibrin formation in
normal plasma was simulated using the original model
(Fig. 4 A). Fibrin production over time was nonlinear, with
almost zero initial slope followed by exponential rise, as
retained in the reduced model (Fig. 4 B):
Fibrin: x1 ¼ y1jt¼ 0


1 e
b6
y1 jt¼ 0


e
b5  x3 jt¼ 0 ð1eb2  tÞ1

zb6
 eb5  b2  x3jt¼ 0  t  1; if t << 1
b2
¼ 110 min:
(4)
The complete and the reduced models predict exactly
identical results for initial stages of clotting or for low TF
concentrations.
To test this prediction, experimental studies in citrate-
anticoagulated plasma, where coagulation was initiated by
addition of TF and calcium, were performed. In agreementBiophysical Journal 98(9) 1751–1761
FIGURE 4 The effect of factor V on
the time course of clotting. Theoretical
(A, B, D, and E) and typical experi-
mental (C and F) kinetics of clotting
in normal (A–C) and factor V-deficient
(D–F) plasma. (A and D) Computer
simulations using the original model;
(B and E) reduced model (Eqs. 2);
(C and F) experiments. TF concentra-
tions are: (A and B) 0.64, 0.32, 0.16,
0.08, 0.04, 0.02, 0.01, and 0 pM, top
to bottom; (D and E) 64, 32, 16, 8, 4,
2, 1, and 0 pM, top to bottom; and
(C and F) shown in the figure.
1756 Panteleev et al.with predictions and current concepts (35), the fibrin gener-
ation had a nonlinear profile with a lag time followed by
a rapidly escalating increase (Fig. 4 C). Consideration of
the reduced system having a single factor V-dependent feed-
back suggests that this nonlinearity is due to factor V activa-
tion by thrombin. Additional analysis (Supporting Material)
confirms that, without this feedback, thrombin would follow
a decaying exponent, and fibrin would be linear during the
initial periods:
IIa: x2 ¼ a3  b3
a5
 x3jt¼ 0  eb2  t: (5)
Fibrin: x1 ¼ y1jt¼ 0


1 e 1y1 jt¼ 0 
a7  a3  b3  x3 jt¼ 0
a5  b2  ð1e
b2  tÞ

z
a7  a3  b3  x3jt¼ 0
a5
 t;
if t <<
1
b2
¼ 110 min:
(6)
Accordingly, computer simulations using the original (Fig. 4
D) and the reduced (Fig. 4 E) mathematical models predicted
a linear dependence for fibrin formation.
To test this, experimental studies were performed in factor
V-deficient plasma (Fig. 4 F). In good agreement with the
prediction, kinetics of fibrin generation without factor V
was linear, and not sigmoidal as in normal plasma (Fig. 4 C),
thus confirming the role of the factor V-dependent positive
feedback in the explosive coagulation response.
To estimate the sigmoidal nature of the curves in Fig. 4
more quantitatively, the data were fitted using the Hill func-
tion. The theoretical Hill parameters (means 5 SEs) for
normal and factor V-deficient plasma were 4.25 0.6 (n¼ 7)
and 1.3 5 0.1 (n ¼ 7), respectively; the corresponding
values for experimental curves were 3.7 5 0.2 (n ¼ 18)
and 1.4 5 0.2 (n ¼ 5). This confirms the effect of factor
V on the explosive response of coagulation.Biophysical Journal 98(9) 1751–1761Final ﬁbrin as a function of activation: triggering
At large times and small TF concentrations, the final fibrin
concentration achieved is an exponentially growing function
of initial TF both in the complete (Fig. 5 A) and in the
reduced model:
Fibrin: x1zb6 

eb5  x3jt¼ 0 ð1e
b2  tÞ  1

zb6
 eb5  x3jt¼ 0  1; if t >> 1
b2
¼ 110 min:
(7)
Considering that fibrin concentration is limited by initial
fibrinogen, that there is a threshold fibrin concentration
required for jellification, and that clot strength is increased
with a fibrin concentration increase, this exponent becomes
a triggerlike step function (Fig. 5 A). There is no clotting
at TF < 0.03 pM (fibrin is below jellification threshold),
and clotting is maximal at TF> 0.04 pM. The reduced model
shows that this trigger behavior is also defined by factor V.
Without it, the dependence would be linear, with plateau if
we account for fibrinogen consumption (Fig. 5 B).
Experimental data qualitatively confirm the predictions
for normal plasma (Fig. 5 C). There is no clotting for >5 h
at TF < 0.005 pM, and clot density rapidly increases over
a narrow range of TF concentration until it is maximal.
Interestingly, final clot density as a function of activation in-
factor V-deficient plasma (Fig. 5 D) is not linear as predicted
in Fig. 5 B, but sigmoid like normal plasma (although clot-
ting occurs at dramatically higher TF concentration confirm-
ing a controlling role of factor V). A likely reason is that
congenitally factor V-deficient plasma does not completely
lack factor V activity; an estimated 1% of residual activity
is sufficient to turn the curve into a sigmoid (Fig. 5 B, inset).
Another possible explanation can be some minor contribu-
tion from another positive feedback loop.
Triggering versus threshold
When tclot in simulations (Fig. S5A) or experiments (Fig. S5B)
is plotted versus TF concentration, there is no qualitative
FIGURE 5 The effect of factor V on the stimulus-
response relationship. Theoretical (A and B) and experi-
mental (C and D) dependences of final fibrin clot density
(after 5 h) on TF concentration in either normal (A and C)
or factor V-deficient (B and D) plasmas. (A and B, solid
curves) Computer simulations with the original model.
(Dotted curves) Calculationswith reducedmodels. (B, inset)
Compares the curves for complete factor V deficiency (0%
of protein activity) and 1%deficiency. (C) Results presented
are means 5 SE of n ¼ 2 separate experiments each per-
formed in quadruplicate using pools from three normal
plasmas. (D) Results aremeans5SE for n¼ 3 experiments.
Task-Oriented Modular Decomposition 1757difference between normal plasma and factor V deficiency. If
threshold is defined as nonclotting at a nonzero TF concentra-
tion, then it exists independently of feedbacks (Fig. S5). This
illustrates the difference between definitions of threshold dis-
cussed above. These experiments show that coagulation has
two distinct threshold-related properties: the activation trig-
gering that ensures rapid, complete, and irreversible transition
of plasma from fluid to the stable gel state; and the jellification
point threshold that causes nonclotting at low TF.
Clotting in factor VIII-deﬁcient plasma
To test the prediction that factor VIII-dependent feedback
regulates neither triggering nor threshold, clot formation
experiments were performed in factor VIII-deficient plasma
(Fig. S6). The effect of factor VIII was small and observable
only at times larger than clot time (panels A and B), and in
a narrow range of TF concentrations (panels C–F).DISCUSSION
Here we proposed and tested an approach for modular
decomposition and analysis of biological networks. The
principal results are:
1. The approach was proposed and tested with blood coag-
ulation.
2. The controlling role of factor V activation by thrombin in
coagulation triggering was identified and confirmed
experimentally.
3. The data, together with previous reports, allow segrega-
tion of coagulation into a number of modules each
responsible for a specific subtask.
That factor V-dependent feedback is the principal part of
the module responsible for triggering, is in line with previoustheoretical studies predicting that positive feedbacks play
crucial roles in creating an explosive response (18,19) and
with their established role in formation of triggers (36).
Our study adds:
1. Elucidation of the specific form of triggering in coagula-
tion, i.e., exponential nonlinearity instead of bistability.
2. Identification of the specific responsible feedback.
3. Experimental confirmation.
An essential difference between previous studies and
ours is that factor V-dependent feedback in our case gener-
ates a sigmoid response, but not bistability. The principal
reason is that early models assumed that activating signal
does not decay, but factor Va is instead rapidly inhibited
(18). In contrast, we take into account experimental evi-
dence that extrinsic tenase is inhibited by TFPI, and factor
Va accumulates; because of this and of pro-cofactor con-
sumption, there is no true steady state in our model but
zero. If one neglects consumption, it is possible to find
bistability in our model of coagulation as well (Fig. 3 C).
However, it results from another feedback, factor XI activa-
tion by thrombin. The bistability has no role in fibrin forma-
tion because factors VIII, IX, and XI become effective only
at times larger than tclot (Fig. S2 B and Fig. S6). We spec-
ulate that the importance of this dynamical feature can be
seen only if coagulation is considered as a two- or three-
dimensional reaction-diffusion process, where bistability
becomes essential for spatial propagation (10,22). One
might even hypothesize that an advantage of nonlinearity
versus bistability in the triggering of this network is that
bistability is usually linked to the spatial self-sustained
expansion of the excited state in an active medium. From
a physiological point of view, it might be desirable to
uncouple triggering and spatial propagation for safetyBiophysical Journal 98(9) 1751–1761
FIGURE 6 Constructing a trigger: temporal and terminal responses of
different enzyme cascades. The diagram illustrates the effect of cascade
structure on their response. The cascades (A–D) begin with an initial signal
(enzyme E1), which is a decaying exponent. On the right, two system
responses are shown: the dependence of the product P concentration on
time (temporal response), and the dependence of the final (achieved at infin-
ite time) concentration of P on the amplitude of the initial signal (terminal
response). In a simple one-step cascade (A), both dependences are linear
near zero. Addition of steps in a cascade (B) can make the temporal response
nonlinear, with no effect on the terminal response. If the added step is a
rapid variable (C), even this advantage is lost. However, a positive feedback
(D) can make both responses nonlinear and create a true trigger. This latter
case corresponds to blood coagulation if E1 is factor Xa, E2 is thrombin, and
P is fibrin.
1758 Panteleev et al.reasons, and that might explain why coagulation triggering
is a nonlinearity, and not a bistability.
Our experiments on clotting in normal, factor V-, and
factor VIII-deficient plasmas confirmed the following model
predictions:
Prediction 1. Existence of an explosive response in
normal plasma.
Prediction 2. Disappearance of this explosive response in
factor V-deficient plasma.
Prediction 3. Existence of nonclotting at low TF concen-
trations.
Prediction 4. Sigmoid dose-response to TF addition in
normal plasma.
Prediction 5. Effects 1, 3, and 4 are retained in factor VIII-
deficient plasmas.
These prediction were not intuitively obvious or expected
with the exception of Prediction 1 (35). The only prediction
that was not confirmed experimentally was dose-response in
factor V-deficient plasma. It turned out to be sigmoid, and
not linear as predicted; this can be explained by trace
amounts of factor V in this plasma.
An assumption and limitation of this study is that it
considers homogeneous systems only. Although its results
are likely to be applicable to initial stages of blood coagula-
tion in the spatially heterogeneous systems as discussed
above, additional regulation by diffusion and flow may
occur. For example, our previous data indicated that clotting
initiation in a reaction-diffusion system can be regulated by
factor Xa diffusion (10). Furthermore, there are theoretical
and experimental reports on coagulation triggering regula-
tion by the size of the activating region (20,21), and by
flow velocity (20,25,33). Additional studies are required to
elucidate the molecular mechanisms that control these spatial
phenomena.
In our experiments, there was no normal plasma jellifica-
tion for >5 h at TF concentrations <~0.005 pM. This agrees
with a recent report that clot formation in blood or plasma
activated with immobilized TF depends on TF surface
density in a thresholdlike manner (32). Most curiously, we
observed that this fibrin jellification threshold was retained
in the absence of factor V; only explosive, nonlinear re-
sponse was lost in factor V-deficient plasmas. Our decompo-
sition of coagulation suggests that these two features, i.e.,
activation triggering, with its strongly nonlinear dependence
of fibrin formation on TF concentration, and fibrin jellifica-
tion threshold, which is nonclotting at low TF, are distinct
properties regulated by different modules.
These conclusions are illustrated by Fig. 6, where tem-
poral and terminal responses of several hypothetical enzyme
cascades are shown. If the coagulation cascade consisted
of a single reaction, both dependences on time and on the
activator concentration would be linear near the point of
origin (Fig. 6 A). Addition of a second step into the cascade
would only add second-order temporal kinetics (Fig. 6 B). If
the concentration of the enzyme in this step were a rapidBiophysical Journal 98(9) 1751–1761variable (as really is the case with factor Xa and thrombin),
even this advantage would be lost (Fig. 6 C). Addition of
a feedback to this latter case would change the situation,
dramatically transforming both dependences into exponen-
tial growth and making them triggerlike (Fig. 6 D); and
this is the case of blood coagulation. All four cascades do
not have a true threshold in form of a bistability. However,
if product P polymerizes in a threshold manner, all four
cascades would have a polymerization threshold in their
ultimate response.
It is tempting to link threshold properties of clotting with
the problem of circulating TF in blood (26,32). The results of
this study allow us to speculate that fibrin jellification
threshold in coagulation might be specifically important in
the prevention of clotting from low concentrations of circu-
lating TF. In contrast, factor V-dependent triggering might
be critical for prevention of weakly attached infirm thrombi
with low fibrin content, because it minimizes temporal and
parametrical intervals where the clot is not firm. Indeed,
sufficient rate of thrombin generation is required to form
solid clots with dense fibrin fibers (35), and low-density clots
could, due to blood flow stress, become detached and
occlude downstream vessels. One prediction that follows is
that factor V deficiency could lead to thromboembolism
because of the increased possibility of infirm thrombi forma-
tion. Most curiously, there are indeed paradoxical reports
that factor V deficiency (which is a rare congenital bleeding
FIGURE 7 Modular decomposition of blood coagulation. Findings of this
study combined with those from other reports allow us to identify six
modules responsible for different subtasks. The reduced models (Eqs. 1
and 2) of this study include modules 1, 2, and 3.
Task-Oriented Modular Decomposition 1759disorder) can be accompanied by recurrent thromboembo-
lism (37,38).
Two studies recently reported that jawless vertebrates
have fewer positive feedback loops in coagulation (39) or
even none (40). It might be speculated that lower flow veloc-
ities and pressures in lamprey make thrombus disruption and
embolization less probable, and trigger in coagulation less
essential, than in higher vertebrates.
Development of another method of network analysis is
justified by problems currently encountered when dealing
with complex and time-dependent networks. Blood coagu-
lation provides a good example: existing bottom-up models
of coagulation are large sets with up to 100 differential
equations, and their analysis is complex and nonintuitive.
The only available strategies were direct simulations
(10,27) or various forms of time-dependent sensitivity
analysis (15,16). However, these methods were not able
to give a comprehensive response to the principal ques-
tions: Why is coagulation so complex? What are these
reactions for? How can we control this system pharmaco-
logically?
The principal idea of our task-oriented modular decompo-
sition is based on the hypothesis that biological networks can
be divided into modules, each being responsible for a specific
subtask. This line of thinking received significant develop-
ment in the analysis of bacterial stress response (7,8). In
coagulation, there also were attempts to ascribe specific roles
to individual reactions (10,17,22,23). A new element in our
approach is use of task-oriented necessity and sensitivity
analysis as a simple and nonbiased method to identify the
modules in question, supplemented with temporal hierarchy
reduction to enable us to understand their structure. Findings
of this study and data from previous reports allow us to
suggest the following decomposition of coagulation into
modules (Fig. 7):
1. Cascade skeleton: no regulation (this study). Curiously,
the cascade does not affect clot formation kinetics. Its
only apparent function is to provide foundation, upon
which the regulation is built. All concentrations of factors
of the cascade are rapid variables; therefore, without
feedbacks, thrombin kinetics (Eq. 5) would be identical
to that of factor VIIa-TF (Eq. 2). The old hypothesis that
the cascade functions as a signal amplifier (41) does not
seem convincing either. From the evolutional point of
view, it would bemuch simpler to achieve the same ampli-
fication with a single rapid reaction than with a cascade of
numerous slow ones.
2. Threshold: fibrin polymerization (previous reports and
this study). Final fibrin concentration is a nonlinear func-
tion of TF (Fig. 5 A) albeit a smooth one. Most likely,
clotting has a threshold (Fig. 5 C) because fibrin polymer-
ization itself has a threshold (29,30).
3. Triggering: positive feedback of factor V activation (this
study).4. Regulation by flow: positive feedback of factor VII
activation (previous reports). Computer simulations of
proteolytic cascades in flow (20) suggested that posi-
tive feedbacks can switch clotting on and off, depend-
ing on the wall shear rate that prevents clotting in the
presence of rapid flow. That the wall shear rate does,
indeed, switch clotting on and off has been recently
confirmed experimentally (33). Simulations using a
mechanism-driven mathematical model suggested that
factor VII activation by factor Xa is responsible for
this (25).
5. Spatial propagation: positive feedbacks of factor VIII and
factor XI activation (previous reports). Roles of these
feedbacks become clear only in spatially nonuniform
systems, where these pathways regulate spatial propaga-
tion of coagulation from the TF-bearing cells to platelets
and into the bulk of plasma (14,17,22,23).
6. Termination of spatial propagation: negative feedback
of protein C pathway (previous reports). This feedback
can function to localize spatial clot propagation (10),
but has no effect on the initial stages of coagulation
(this study).
Coagulation provides an interesting example of an
enzyme network, which can be rather minutely decomposed
into modules. Its major positive feedbacks are used for a
variety of purposes, such as triggering an explosive response,
for self-sustained spatial propagation, or to create a flow-
dependent switch. Its negative feedback is used for better
control of spatial propagation. Decomposition appears to
leave no redundant components in the network, although
our consideration was focused on coagulation alone and
necessarily excluded many links to other systems (platelet-
dependent hemostasis, immunity, and angiogenesis); their
analysis can be a task for future research.
Current therapeutic strategies are usually based on the
approximation that impacts of drugs are either pro- or
anticoagulant, without regard for complexity of the networkBiophysical Journal 98(9) 1751–1761
1760 Panteleev et al.response; and the consequence is that treatment of thrombosis
can be associated with danger of bleeding. This analysis
suggests that this can be resolved by targeting specific reac-
tions to selectively regulate its properties such as the activa-
tion threshold level or size of the thrombus.SUPPORTING MATERIAL
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